Singapore markets closed

MEDIROM Healthcare Technologies Inc. (MRM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.9200+0.1300 (+3.43%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
115,049
115,049
148,965
-990,731
-539,170
-
Depreciation & amortisation
252,595
252,595
184,056
126,243
62,290
-
Deferred income taxes
-101,636
-101,636
0
551,483
-107,264
-
Stock-based compensation
0
0
0
196,853
0
-
Change in working capital
318,869
318,869
-136,723
1,249
76,311
-
Accounts receivable
580,681
580,681
-222,384
-37,024
189,143
-
Inventory
-25,873
-25,873
-95,406
-2,441
-2,445
-
Accounts payable
-69,884
-69,884
-23,318
58,437
-55,574
-
Other working capital
-1,553,755
-1,553,755
-852,198
-671,009
-470,545
-
Other non-cash items
45,718
45,718
-
819
1,903
-7,382
Net cash provided by operating activities
-631,737
-631,737
-685,697
-557,231
-366,420
-
Cash flows from investing activities
Investments in property, plant and equipment
-922,018
-922,018
-166,501
-113,778
-104,125
-
Acquisitions, net
0
0
-148,000
-375,757
-99,195
-
Purchases of investments
-3,094
-3,094
0
-78,922
-26,703
-
Sales/maturities of investments
0
0
0
6,000
63,000
-
Other investing activities
11,768
11,768
2,599
48,521
24,197
-
Net cash used for investing activities
-328,576
-328,576
580,437
-83,936
-139,599
-
Cash flows from financing activities
Debt repayment
-99,084
-99,084
-207,522
-251,084
-386,440
-
Common stock issued
-
-
0
0
1,168,627
700,000
Other financing activities
160,290
160,290
-
-264,507
-131,806
-126,095
Net cash used provided by (used for) financing activities
461,206
461,206
340,097
-427,949
1,432,131
-
Net change in cash
-499,107
-499,107
234,837
-1,069,116
926,112
-
Cash at beginning of period
605,454
605,454
370,617
1,439,733
513,621
-
Cash at end of period
106,347
106,347
605,454
370,617
1,439,733
-
Free cash flow
Operating cash flow
-631,737
-631,737
-685,697
-557,231
-366,420
-
Capital expenditure
-922,018
-922,018
-166,501
-113,778
-104,125
-
Free cash flow
-1,553,755
-1,553,755
-852,198
-671,009
-470,545
-